Collplant Biotechnologies Ltd
NASDAQ:CLGN
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Price:
5.85 USD
-1.68%
Market Closed
Updated:
May 7, 2024
Collplant Biotechnologies Ltd
Net Income (Common)
|
Collplant Biotechnologies Ltd
Net Income (Common) Peer Comparison
Comparables:
KMDA
B
BLRX
URGN
ENTX
B
BONS
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Net Income (Common)
-$7m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Net Income (Common)
$8.3m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
34%
|
|
B
|
BioLine RX Ltd
TASE:BLRX
|
Net Income (Common)
-$60.6m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
-14%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Net Income (Common)
-$102.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Net Income (Common)
-$8.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Net Income (Common)
-₪31m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-12%
|
See Also
What is Collplant Biotechnologies Ltd's Net Income (Common)?
Net Income (Common)
-7m
USD
-7m
USD
Based on the financial report for Dec 31, 2023, Collplant Biotechnologies Ltd's Net Income (Common) amounts to -7m USD.
What is Collplant Biotechnologies Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-2%
-2%
Over the last year, the Net Income (Common) growth was 59%. The average annual Net Income (Common) growth rates for Collplant Biotechnologies Ltd have been -7% over the past three years , -2% over the past five years .
You don't have any saved screeners yet
